
The next numbers are a snapshot of the performance that represents the first semester of 2019:

Instruments:
Hemostasis
Since ACL Top launch in the hemostasis market we delivered more than 1200 units; as of the end of June more than 130 units have been shipped split evenly between the ACL TOP Family and the ACL Elite Family and most amazing of all already in May of 2019 the Hemostasis Business Line crossed the 100 units shipped since the start of the year.
Autoimmunity:
By the end of june 2019 the Autoimmunity Business Line crossed 120 units of BIO-FLASH in clinical use. EEMEAI is the leading worldwide geography in terms of BIO-FLASH in clinical use. Also, we placed our very first QUANTA-Lyser 3000 in India at one of the biggest private laboratory chain in New Delhi.
Acute Care Diagnostics:
By the end of june 2019bthe Acute Care Diagnostics Business Unit shipped 589 instruments in EEMEAI including GEM, ROTEM, Hemochron, VerifyNow and Avoximeter analyzers. So far, we have shipped 70 units of GEM Premier 5000 since its launch in EEMEAI.
Tests:
Hemostasis
A capacity of more than 50 million tests has already been shipped with >40 million tests on the ACL TOP Family and > 10 Million tests on the ACL Elite Family; in the EEMEAI area we shipped across all platforms more than 13 Million PT and another 13 Million aPTTs and more than 1.3 Million DDimer tests. Regarding Chemiluminescence, we have crossed 50.000 tests shipped in our region to be performed on the AcuStar.
Autoimmunity:
The first semester of 2019 shows 35% growth of QUANTA Flash reagents compared to the first half of 2018.
Acute Care Diagnostics:
Keeping up with the Acute Care Diagnostics Strategy of focusing on point of care, the Patient Blood Management business line more than doubled the sales of ROTEM Sigma cartridges in June 2019 compared to that of June 2018.
There is a 5% increase in total sales of Hemochron, VerifyNow, Avoximeter and Tenderfoot product lines. This includes:
|
News
Hemostasis:
Breaking News: We are currently finalizing the installation of HemoHub in three sites, one of these sites has a HemoCell that is ready for clinical use.
Acute Care Diagnostics:
GEMweb Plus:
Finally, there were more than 3 new installations of GEMweb Plus leading to a total of 24 installations in EEMEAI
Autoimmunity:
First integrated lab in Finland: we won in the western and central lab with QUANTA-Lyser 3000, NOVA View and QUANTA Link.
Tender with 4 BIO-FLASH was awarded to Werfen at the largest healthcare network of United Arab Emirates (UAE), from the Al Dhafra Region to the eastern region of UAE.
Werfen Czech has won the first tender for autoimmunity with an Integrated Lab in Prague. In this competitive tender against Dynex (distributor of Euroimmun) we will install NOVA View, QUANTA-Lyser, BIO-FLASH and QUANTA Link.
Let's celebrate with big applause and heartfelt congratulations to every single one of you who played a part in delivering amazing results!
the EEMEAI Team



